The prevalence of diabetes and pre-diabetes in the US is now a staggering 51%. It has become increasingly clear that development of both type 1 and type 2 diabetes depends upon the ability or inability of the islet ? cell to adapt to prevailing stresses in either disease. Elucidating the molecular mechanisms of the ? cell response in diabetes has remained a long-standing objective of this R01 award over the years. My laboratory has recently focused on defining how mRNA translation in the ? cell is regulated in response to diabetogenic stresses. The translation factor eIF5A functions as an acute response factor in the ? cell that either activates translation of specific mRNAs, enabling the requisite cellular response. Notably, eIF5A is the only protein containing the unique amino acid hypusine. When ?hypusinated,? eIF5A permits translation of specific mRNAs; when ?unhypusinated,? eIF5A is dysfunctional. The formation of hypusine is governed by two rate-limiting enzymes, ornithine decarboxylase (ODC) and deoxyhypusine synthase (DHS). ODC generates intracellular polyamines from ornithine, and DHS utilizes the polyamine spermidine to form hypusine on eIF5A. Because polyamines and hypusine can be manipulated by diet or clinically available small molecule inhibitors, they represent real-world targets to intervene in human diabetes pathogenesis. This application takes a distinctly disease-specific approach to understand better the role of the polyamine/hypusine pathway in type 1 and type 2 diabetes. We hypothesize that the pathway that generates polyamines and hypusine integrates extracellular diabetogenic signals to promote stress-specific mRNA translation in the islet ? cell. We believe we are uniquely positioned with the expertise in ? cell biology and mRNA translation and with unique reagents?? including novel conditional KO mice, mRNA translation assessment tools, and access to clinical trial samples? ?to test this hypothesis. We propose the following 3 aims Aim 1: Interrogate the mechanism by which the polyamine/hypusine pathway contributes to the translation of specific mRNAs in islet ? cells.
Aim 2 : Determine the adaptive and maladaptive roles of the polyamine/hypusine pathway in ? cell compensation and dysfunction, respectively, in insulin resistance.
Aim 3 : Define the roles of hypusine and polyamines during the pathogeneses of mouse and human type 1 diabetes. We believe the major impact of these studies will be to identify a new tractable pathway that contributes to the adaptive and maladaptive responses of the ? cell to inflammatory, ER, and oxidative stresses. Because manipulation of this pathway is achievable with small molecule inhibitors, these studies will provide the first evidence for the feasibility of these inhibitors in the treatment of diabetes.

Public Health Relevance

Dysfunction and death of the insulin-producing ? cell underlies virtually forms of diabetes, and a better understanding of the mechanisms that give rise to ? cell dysfunction will be crucial to developing new therapies. Polyamines and hypusine are polycationic amines that function in cellular responses to stresses. Using novel mouse models and human studies, we will interrogate the role of polyamines and hypusine in ? cell dysfunction in type 1 and type 2 diabetes, with the intent of eventually targeting these molecules in the treatment of both major forms of diabetes.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Sato, Sheryl M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Medicine
United States
Zip Code
Mastracci, Teresa L; Turatsinze, Jean-Valery; Book, Benita K et al. (2018) Distinct gene expression pathways in islets from individuals with short- and long-duration type 1 diabetes. Diabetes Obes Metab 20:1859-1867
Mulukutla, Surya N; Tersey, Sarah A; Hampe, Christiane S et al. (2018) Elevated unmethylated and methylated insulin DNA are unique markers of A+?+ ketosis prone diabetes. J Diabetes Complications 32:193-195
Marasco, Michelle R; Conteh, Abass M; Reissaus, Christopher A et al. (2018) Interleukin-6 Reduces ?-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response. Diabetes 67:1576-1588
Sims, Emily K; Park, Grace; Mather, Kieren J et al. (2018) Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function. PLoS One 13:e0197080
Beli, Eleni; Yan, Yuanqing; Moldovan, Leni et al. (2018) Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice. Diabetes 67:1867-1879
Sims, Emily K; Evans-Molina, Carmella; Tersey, Sarah A et al. (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61:2259-2265
Simons, Zachary B; Morgan, Rachel C; Rose, Laurel et al. (2018) Hypoglycemia in a Patient With a Polyhormonal Pancreatic Neuroendocrine Tumor With Evidence of Endocrine Progenitors. J Endocr Soc 2:172-177
Samala, Niharika; Tersey, Sarah A; Chalasani, Naga et al. (2017) Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase. J Diabetes Complications 31:1630-1637
Blandino-Rosano, Manuel; Barbaresso, Rebecca; Jimenez-Palomares, Margarita et al. (2017) Loss of mTORC1 signalling impairs ?-cell homeostasis and insulin processing. Nat Commun 8:16014
Hatanaka, Masayuki; Anderson-Baucum, Emily; Lakhter, Alexander et al. (2017) Chronic high fat feeding restricts islet mRNA translation initiation independently of ER stress via DNA damage and p53 activation. Sci Rep 7:3758

Showing the most recent 10 out of 80 publications